Return to Newsroom & Events > Get Connected



Makena and Compound 17P

Midwives: Were talking with other professional societies about the use of Makena to prevent premature birth, and we need your input! Feel free to comment below or e-mail comments to mgreenfield@acnm.org:

  • Do you prescribe synthetic progestin to patients who have a history of preterm birth? 
  • If so, do you prescribe Makena or the generic compound (17P)?*
  • If you prefer 17P over Makena, is it due to cost or an issue of access? 
  • Do you feel safe prescribing 17P?
  • Have you noticed any adverse reactions from Makena or 17P?
  • Do your clients have issues accessing or affording these medications?
  • Have you had any issues with insurance companies when you prescribe these medications? 
  • Is insurance covering Makena? 
  • Have you had patients who need Makena but did not have Medicaid or other insurance and are unable to get Makena? 
  • What are the costs of 17P vs. Makena?

Please share your experience! (Please remember to protect patient privacy by observing HIPAA regulations.)

*17P is not a generic version of Makena. Compounded drugs are not approved or regulated by the FDA.

Posted 9/22/2011 11:11:40 AM
 

 

 



Any opinions expressed in this blog are those of the individual participant(s) and do not necessarily reflect the views of the American College of Nurse-Midwives. ACNM is not responsible for accuracy of any of the information provided by guest bloggers and/or members via the Comments section. We welcome all feedback including comments, ideas and suggestions. We also welcome civil, friendly debates. However, any and all content that is deemed inflammatory or rude will not be posted.

 

2010 American College of Nurse-Midwives. All Rights Reserved. 8403 Colesville Rd, Suite 1550 Silver Spring MD 20910 Phone: 240-485-1800 Fax: 240-485-1818
space